← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $4.5M of United Therapeutics Corporation

Sold$4,523,635
$476.17Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Sep 28Copier in Sep 29
The stock from Tue, Sep 29 open, $485.54
+11.9%
S&P 500, same days
0.0%

14 of 30 trading days so far, to the Oct 19 close.

Traded Fri, Sep 25. Filed Mon, Sep 28, 4:30 PM ET, after the close. Returns use the Sep 29 open and the Oct 19 close. Not investment advice.